Detected ·
Humanetics Corporation
——
Humanetics Corporation, a biotech developing BYOGRAYZ™ for radiation protection and oncology applications, is raising a $10M Series B. The therapy has received over $100M in federal support from the Department of Defense and is being developed for Acute Radiation Syndrome prevention, cancer treatment, and inflammatory pulmonary diseases.
- Website
- www.humaneticscorp.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-20 21:03:35 UTC
- Signal ID
- 71ead003-b570-4ef4-9ab7-c1f1ba1c3ede
As the API returns it
{
"id": "71ead003-b570-4ef4-9ab7-c1f1ba1c3ede",
"created_at": "2026-04-20T21:03:35.367249Z",
"company_name": "Humanetics Corporation",
"company_website_url": "www.humaneticscorp.com",
"company_linkedin_url": "https://www.linkedin.com/company/humanetics-corporation",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Humanetics Corporation, a biotech developing BYOGRAYZ™ for radiation protection and oncology applications, is raising a $10M Series B. The therapy has received over $100M in federal support from the Department of Defense and is being developed for Acute Radiation Syndrome prevention, cancer treatment, and inflammatory pulmonary diseases.*"
}